Your browser doesn't support javascript.
loading
An HPLC-SEC-based rapid quantification method for vesicular stomatitis virus particles to facilitate process development.
Schimek, Adrian; Ng, Judy K M; Basbas, Ioannes; Martin, Fabian; Xin, Dongyue; Saleh, David; Hubbuch, Jürgen.
Afiliación
  • Schimek A; ViraTherapeutics GmbH, Bundesstraße 27, 6063 Rum, Austria.
  • Ng JKM; ViraTherapeutics GmbH, Bundesstraße 27, 6063 Rum, Austria.
  • Basbas I; ViraTherapeutics GmbH, Bundesstraße 27, 6063 Rum, Austria.
  • Martin F; ViraTherapeutics GmbH, Bundesstraße 27, 6063 Rum, Austria.
  • Xin D; Boehringer Ingelheim Pharmaceuticals Inc, 900 Ridgebury Road, Ridgefield, CT 06877, USA.
  • Saleh D; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397 Biberach, Germany.
  • Hubbuch J; Karlsruhe Institute of Technology, Institute of Process Engineering in Life Sciences, Section IV Biomolecular Separation Engineering, Fritz-Haber-Weg 2, 76131 Karlsruhe, Germany.
Mol Ther Methods Clin Dev ; 32(2): 101252, 2024 Jun 13.
Article en En | MEDLINE | ID: mdl-38774583
ABSTRACT
Virus particle (VP) quantification plays a pivotal role in the development of production processes of VPs for virus-based therapies. The yield based on total VP count serves as a process performance indicator for evaluating process efficiency and consistency. Here, a label-free particle quantification method for enveloped VPs was developed, with potential applications in oncolytic virotherapy, vaccine development, and gene therapy. The method comprises size-exclusion chromatography (SEC) separation using high-performance liquid chromatography (HPLC) instruments. Ultraviolet (UV) was used for particle quantification and multi-angle light scattering (MALS) for particle characterization. Consistent recoveries of over 97% in the SEC were achieved upon mobile phase screenings and addition of bovine serum albumin (BSA) as sample stabilizer. A calibration curve was generated, and the method's performance and applicability to in-process samples were characterized. The assay's repeatability variation was <1% and its intermediate precision variation was <3%. The linear range of the method spans from 7.08 × 108 to 1.72 × 1011 VP/mL, with a limit of detection (LOD) of 7.72 × 107 VP/mL and a lower limit of quantification (LLOQ) of 4.20 × 108 VP/mL. The method, characterized by its high precision, requires minimal hands-on time and provides same-day results, making it efficient for process development.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Ther Methods Clin Dev Año: 2024 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Ther Methods Clin Dev Año: 2024 Tipo del documento: Article País de afiliación: Austria
...